Oxford Nanopore Technologies plc (ONTTF)
USD 1.8
(-7.69%)
USD 1.8
(-7.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -126.98 Million GBP | -108.49% |
| 2022 | -60.9 Million GBP | 56.24% |
| 2021 | -140.4 Million GBP | -150.17% |
| 2020 | -55.07 Million GBP | 15.22% |
| 2019 | -65.02 Million GBP | -18.79% |
| 2018 | -55.24 Million GBP | 13.8% |
| 2017 | -64.09 Million GBP | -0.75% |
| 2016 | -63.61 Million GBP | -47.21% |
| 2015 | -43.21 Million GBP | -5.47% |
| 2014 | -40.97 Million GBP | -46.32% |
| 2013 | -28 Million GBP | -24.08% |
| 2012 | -22.56 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -57.24 Million GBP | 0.0% |
| 2023 Q2 | -54.91 Million GBP | -66.31% |
| 2023 Q3 | -42.19 Million GBP | 23.16% |
| 2023 Q4 | -72.06 Million GBP | -70.79% |
| 2023 FY | - GBP | -108.49% |
| 2023 Q1 | -33.01 Million GBP | 44.76% |
| 2022 Q4 | -59.77 Million GBP | -73.61% |
| 2022 Q1 | -6.8 Million GBP | 93.72% |
| 2022 Q2 | 31.05 Million GBP | 556.58% |
| 2022 Q3 | -34.42 Million GBP | -210.85% |
| 2022 FY | - GBP | 56.24% |
| 2021 Q1 | -16.23 Million GBP | 25.05% |
| 2021 FY | - GBP | -150.17% |
| 2021 Q4 | -108.28 Million GBP | -81.8% |
| 2021 Q2 | -31.55 Million GBP | -94.38% |
| 2021 Q3 | -59.56 Million GBP | -88.76% |
| 2020 Q4 | -21.65 Million GBP | -56.07% |
| 2020 Q1 | -17.59 Million GBP | 0.0% |
| 2020 Q2 | -34.06 Million GBP | -93.67% |
| 2020 Q3 | -13.87 Million GBP | 59.27% |
| 2020 FY | - GBP | 15.22% |
| 2019 FY | - GBP | -18.79% |
| 2018 FY | - GBP | 13.8% |
| 2017 FY | - GBP | -0.75% |
| 2016 FY | - GBP | -47.21% |
| 2015 FY | - GBP | -5.47% |
| 2014 FY | - GBP | -46.32% |
| 2013 FY | - GBP | -24.08% |
| 2012 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -78.757% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -2041.743% |
| SQZ Biotechnologies Company | -64.14 Million USD | -97.973% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -631.042% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 235.032% |
| Mesoblast Limited | -62.38 Million USD | -103.53% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -8166.794% |
| Genus plc | 73.7 Million USD | 272.296% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -1820.618% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -3479.985% |
| Marizyme, Inc. | -34.28 Million USD | -270.41% |
| ContraFect Corporation | -64.99 Million USD | -95.36% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -1347.583% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -2705.491% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -8958.445% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -4701.834% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -5364.365% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -24411.723% |
| Accustem Sciences Inc. | -3.74 Million USD | -3289.423% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -163.301% |
| EV Biologics, Inc. | -1.26 Million USD | -9921.213% |
| Q BioMed Inc. | -617.62 Thousand USD | -20459.625% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 3654.927% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -19979.19% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -5458.442% |
| Biomind Labs Inc. | -1.03 Million USD | -12174.141% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 1385.633% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -1673.176% |
| Skye Bioscience, Inc. | -13.54 Million USD | -837.306% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -8437.11% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -507828.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -3169.092% |
| IMV Inc. | -35.52 Million USD | -257.46% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -700.152% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -4975.297% |
| GB Sciences, Inc. | -1.41 Million USD | -8843.119% |
| Alpha Cognition Inc. | -9.7 Million USD | -1208.337% |
| HST Global, Inc. | -5303.00 USD | -2394431.397% |
| CSL Limited | 4.78 Billion USD | 102.652% |
| Halberd Corporation | -74.27 Thousand USD | -170852.759% |
| Enzolytics Inc. | -2.12 Million USD | -5883.99% |
| Resverlogix Corp. | -11.74 Million USD | -981.434% |
| Affymax, Inc. | -14.29 Million USD | -788.297% |
| SYBLEU INC | -141.57 Thousand USD | -89594.923% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -4045.653% |
| argenx SE | -216.02 Million USD | 41.218% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -129.462% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 10534.018% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -8371.645% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 33618.282% |
| AVAX Technologies, Inc. | -6.11 Million USD | -1977.367% |
| Zenith Capital Corp. | -8.6 Million USD | -1375.505% |
| Genscript Biotech Corporation | -248.71 Million USD | 48.946% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -728801.9% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -5090.436% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -72038.879% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -220.363% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -4290.307% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -12036.151% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 1888588.995% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -7156.118% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -6510.509% |
| BioStem Technologies, Inc. | -7.55 Million USD | -1581.069% |
| ONE Bio Corp. | 13.61 Million USD | 1032.797% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -70021.709% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -6073.165% |
| Agentix Corp. | -1.37 Million USD | -9156.894% |
| LadRx Corporation | 412.28 Thousand USD | 30899.718% |
| Cell Source, Inc. | -4.27 Million USD | -2872.059% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -34479.177% |
| Regen BioPharma, Inc. | 1.46 Million USD | 8762.061% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -13452.712% |
| NovAccess Global Inc. | -1.03 Million USD | -12171.199% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 1534.209% |
| Itoco Inc. | -1.86 Million USD | -6694.133% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -33349.766% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -11278.315% |
| Kadimastem Ltd | -2.62 Million USD | -4738.551% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -52997.219% |
| CytoDyn Inc. | -18.02 Million USD | -604.321% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -160577.726% |
| Mobile Lads Corp. | -2.24 Million USD | -5565.908% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -1038267.814% |
| Qrons Inc. | -40.08 Thousand USD | -316713.453% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -26045.306% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 24175.475% |
| Rebus Holdings, Inc. | -951 Thousand USD | -13252.471% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -11856.761% |
| International Stem Cell Corporation | 202 Thousand USD | 62962.376% |
| Bioxytran, Inc. | -3.82 Million USD | -3224.008% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -241127.204% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -5057.819% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -254.016% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -282082.222% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -4537.765% |
| Neutra Corp. | -181.24 Thousand USD | -69960.194% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -529.902% |
| PureTech Health plc | -11.62 Million USD | -992.13% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -529.945% |
| IXICO plc | -707 Thousand USD | -17860.679% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -1552.336% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -162.653% |
| CSL Limited | 4.73 Billion USD | 102.683% |
| Cellectis S.A. | -92.63 Million USD | -37.076% |